See what you missed!

We had a great time sponsoring DIA’s 2024 Global Annual Meeting. Not able to attend? See what you missed.

Transforming R&D with emerging technologies

Life Sciences R&D organizations are under increasing pressure to produce a sustainable return on capital given shifts in the market, regulatory and reimbursement environment. While the industry has recently produced groundbreaking innovation that has the potential to truly transform global health, scaling the impact will require rethinking and transforming the traditional R&D model. Advanced technologies and innovations such as robotics, artificial intelligence (AI), and cognitive automation, real-world evidence (RWE), digital health and telemedicine, can impact R&D across the entire value chain – from drug discovery to clinical trials and regulatory reporting. They will also impact the talent models of many organizations, and how R&D is conducted in the future.